News 2021

2021 News

List of articles in category 2021 News
Title	Created Date
Q BioMed Shows Significant Uptrend in Revenues in Year-End Update	Dec 16, 2021
Q BioMed Bolsters Commercialization of Strontium89 with EVERSANA Partnership	Nov 08, 2021
Q BioMed Inc. Provides Shareholder Update	Oct 25, 2021
Q BioMed Inc. Provides Update on Strontium89 Commercial Roll Out	Sep 28, 2021
Q BioMed Inc. Updates on Covid-19 Therapeutic Development and Clinical Trials - MAN-19 therapeutic program heading to clinical trial in early 2022	Sep 22, 2021
Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent in South Korea and Shows Promising Results in Initial Pre-Clinical Testing	Aug 24, 2021
Q BioMed Signs Distribution Agreement with isoSolutions for the Sales of Strontium89 in Canada	Aug 10, 2021
Q BioMed Signs License Agreement with Clionix for the Distribution and Sales of Strontium89 in Europe and Middle East	Jul 12, 2021
Q BioMed Engages Contract Sales Force with Deep VA and Oncology Experience	May 20, 2021
Q BioMed Insider to Invest up to $30M in the Company	May 11, 2021
Q BioMed Updates Shareholders	Apr 27, 2021
Q BioMed Awarded Federal Supply Contract for Strontium89 with U.S. Department of Defense and Veterans Affairs	Mar 02, 2021
Q BioMed Expands Strontium89 Reach Through Agreement with UroGPO, the Largest Group Purchasing Organization for Independent Urology Clinics in the US	Feb 01, 2021
Q BioMed’s Uttroside-B Receives U.S. FDA Orphan Drug Designation in the Treatment of Liver Cancer	Jan 27, 2021
Q BioMed’s Uttroside-B Receives Additional Patent Coverage in Canada and Japan	Jan 26, 2021
Strontium89 Now Reimbursed in Hospital and Outpatient Settings for Metastatic Bone Pain Treatment	Jan 07, 2021